InsiderTrades

Form 4 for FHTX Foghorn Therapeutics Inc.

Accepted 2024-09-24 00:00:00 ET · period of report 2024-09-20 · accession 0001562180-24-006927 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2024-09-24 2024-09-20+ FHTX Costa Carlos CHRO M - OptEx $3.72 +36.6K 35.8K New +$136.2K
DMT 2024-09-24 2024-09-20+ FHTX Costa Carlos CHRO S - Sale+OE $10.04 -36.6K 0 -100% -$367.7K
DMT 2024-09-24 2024-09-20+ FHTX Costa Carlos CHRO M - OptEx $0.00 -36.6K 40.6K -47% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-23 M A 857 $3.72 857 D — —
2 Common Common Stock 2024-09-20 S D 35,756 $10.04 0 D — — (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 to $10.22 per share.
3 Common Common Stock 2024-09-20 M A 35,756 $3.72 35,756 D — —
4 Common Common Stock 2024-09-23 S D 857 $10.17 0 D — —
5 Derivative Stock Option (right to buy) 2024-09-23 M D 857 $0.00 39,789 D $3.72 · — to 2029-02-12 857 Common Stock (F3) The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.
6 Derivative Stock Option (right to buy) 2024-09-20 M D 35,756 $0.00 40,646 D $3.72 · — to 2029-02-12 35,756 Common Stock (F3) The option vested as to 25% of the underlying shares of common stock on August 29, 2019, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option was fully vested.